Vaccine Boost
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
New spinout to develop gene therapies targeting rare lung diseases
AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.
Study identifies vulnerable groups least likely to have COVID-19 antibodies
Findings from the MELODY study have identified which people with compromised immune systems are less likely to have COVID-19 antibodies.
Feature
In conversation: Mental Health and Stigma with HIV, where are we 40 years on?
In this podcast series, we explore the experience of living with HIV and current research at Imperial on mental health and future treatment options.
COVID-19 spread in households linked to virus on hands and surfaces
A new study provides the first empirical evidence for transmission of SARS-CoV-2 via people’s hands and frequently touched household surfaces.
Rapid virus testing system conceived at Imperial lands new role in entertainment
A new partnership will bring rapid respiratory virus testing to film sets and TV studios across the country.
What Imperial research taught us about COVID-19 in 2022
From increased understanding of immunity to analysing the success of vaccines, we look back at what Imperial taught us about COVID-19 in 2022.
First-line defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline 9 months after infection, while those found in the blood last at least a year.
Two Imperial finalists shortlisted for inaugural MRC Impact Prizes
An MRC Centre for Global Infectious Disease Analysis team and Dr Natalie Shenker from the Dept of Surgery and Cancer are finalists in two categories.
Fusion surprises and COVID scars: News from the College
Here’s a batch of fresh news and announcements from across Imperial.